Elon Musk, the 53-year-old CEO of Tesla and SpaceX, has revealed he uses Mounjaro to help manage his weight. In a festive social media post on Wednesday, Musk explained his decision to use the medication, clarifying that it is not Ozempic, but another GLP-1 inhibitor, which he believes has fewer side effects.
The New York Post reported that Musk shared a playful image of himself dressed as Santa Claus, with a white beard and festive attire, comparing his appearance to "Cocaine Bear, but Santa and Ozempic."
He also jokingly referred to himself as "Ozempic Santa" but emphasized that Mounjaro was his preferred medication, stating, "Technically, Mounjaro, but that doesn’t have the same ring to it."
Mounjaro, like other GLP-1 inhibitors, is a class of medication that helps regulate blood glucose and insulin levels, making it a popular choice for people with diabetes. However, in recent years, it has also gained traction as a weight-loss aid, with many Americans turning to these drugs for their slimming effects.
In his post, Musk explained why he prefers Mounjaro over Ozempic. He shared that high doses of Ozempic made him experience uncomfortable side effects, including "fart & burp like Barney from the Simpson’s." Musk stated that Mounjaro has "fewer side effects and [is] more effective" for him, expressing his satisfaction with the medication’s results.
Mounjaro, along with Ozempic and other GLP-1 inhibitors like Wegovy, has gained attention as an effective tool for weight loss.
These medications are designed to help people lose weight by regulating appetite and food intake, making them appealing to those struggling with obesity. As weight-related health issues continue to rise, more people are turning to medications like Mounjaro to help them manage their weight.
Musk has been open about his use of such drugs in the past, admitting in 2022 that he used Wegovy, another GLP-1 inhibitor, to help with weight management.
His endorsement of these medications is in line with his broader stance on improving public health through pharmaceutical solutions. However, his views contrast with those of Robert F. Kennedy Jr., who has argued that promoting healthier eating habits is a more cost-effective and sustainable approach to tackling obesity.
Musk’s stance has earned him support from some unexpected places. On "The View," Whoopi Goldberg praised Musk’s position on GLP-1 inhibitors, admitting that she too takes Mounjaro. Goldberg, who had struggled with her weight for years, shared that she weighed close to 300 pounds two years ago but lost significant weight after starting Mounjaro. She voiced her support for Musk’s views, saying, "Elon’s right on this!"
Musk’s endorsement of Mounjaro and other GLP-1 inhibitors is part of a larger conversation about the ongoing obesity epidemic in the United States.
According to the Centers for Disease Control and Prevention (CDC), nearly 42% of Americans are considered obese, a statistic that has spurred debates about effective solutions. Musk’s public endorsement of weight-loss medications adds to the growing trend of pharmaceutical treatments being used to combat the issue.
However, not everyone agrees with Musk's approach. Critics like Robert F. Kennedy Jr. argue that promoting healthier eating and lifestyle changes would be a more sustainable solution to obesity. Kennedy has voiced concerns about the cost-effectiveness of relying on medication, especially given the potential side effects and long-term health risks.
Musk’s support for GLP-1 inhibitors aligns with his broader philosophy of embracing technology and innovation to solve societal problems. He has often advocated for solutions that leverage science and medicine to improve public health, particularly in the realm of weight management.
While Musk’s post was lighthearted in tone, it has sparked considerable discussion about the role of medication in addressing obesity.
Many people, particularly those who have used these drugs, have expressed their approval of Musk's open discussion about weight loss medications. Social media users have praised him for being transparent about his experience, seeing it as a positive move toward reducing the stigma around using such drugs.
Musk’s choice to share his personal weight-loss journey comes at a time when the conversation around weight management and medication is growing. With increasing numbers of people turning to drugs like Mounjaro, the debate over the role of pharmaceuticals in health care is likely to intensify.
Beyond his influence in the tech and business worlds, Musk’s views on health and wellness have begun to shape public discourse.
His support for GLP-1 inhibitors, alongside his role in spearheading various technological advancements, positions him as a major voice in the ongoing conversation about health and wellness. As a high-profile figure, Musk's words and actions often have far-reaching effects, with many looking to him as a source of guidance.
As Musk continues to champion the use of GLP-1 inhibitors, it remains to be seen how his stance will influence public perceptions of weight-loss medications. For now, his fans and critics alike are paying close attention to his ongoing discussion of health and fitness, particularly as he navigates his personal journey with Mounjaro.
